Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1986-05-07
1988-06-14
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514866, A61K 31195
Patent
active
047512431
ABSTRACT:
A method is disclosed for improving wound healing by administering an effective amount of tolrestat.
REFERENCES:
patent: 4439617 (1984-03-01), Sestanj et al.
patent: 4568693 (1986-02-01), Sestanj et al.
patent: 4600717 (1986-07-01), York
S. Fukushi et al., "Reepithelialization of Denuded Corneas in Diabetic Rats", Exp. Eye Res. (1980) vol. 31, pp. 611-621.
M. B. Datiles et al. "Corneal Re-epithelialization in Galactosemic Rats", Inves. Ophthalmology & Visual Science, May 1983, vol. 24, pp. 564-569.
Banknieder August R.
Mullane John F.
American Home Products Corporation
Routh John W.
Schenkman Leonard
LandOfFree
Tolrestat for wound healing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tolrestat for wound healing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tolrestat for wound healing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505372